|
Volumn 69, Issue , 2013, Pages 77-89
|
Design, synthesis, and structure-activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents
|
Author keywords
Antiproliferative activity; c Met; Quinoline derivatives; Synthesis
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FORETINIB;
N [3 FLUORO 4 [6 METHOXY 7 (3 MORPHOLINOPROPOXY)QUINOLIN 4 XYLOXY]PHENYL] 4 (2 FLUORPHENYL)PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 (3 MORPHOLINOPROPOXY)QUINOLIN 4 XYLOXY]PHENYL] 4 (2,4 DIMETHOXYPHENYL)PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 (3 MORPHOLINOPROPOXY)QUINOLIN 4 XYLOXY]PHENYL] 4 (4 FLUORPHENYL)PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 (3 MORPHOLINOPROPOXY)QUINOLIN 4 XYLOXY]PHENYL] 4 [4 (METHOXYPHENYL)PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 (3 MORPHOLINOPROPOXY)QUINOLIN 4 XYLOXY]PHENYL] 4 [4 (TRIFLUOROMETHYL)PHENYL]PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 (3 MORPHOLINOPROPOXY)QUINOLIN 4 XYLOXY]PHENYL] 4 O TOLYLPICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 (3 MORPHOLINOPROPOXY)QUINOLIN 4 XYLOXY]PHENYL] 4 P TOLYLPICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 (3 MORPHOLINOPROPOXY)QUINOLIN 4 XYLOXY]PHENYL] 4 PHENYLPICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (4 METHYLPIPERAZIN 1 YL) PROPOXY]QUINOLIN 4 YLOXY]PHENYL] 4 (2 FLUOROPHENYL)PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (4 METHYLPIPERAZIN 1 YL) PROPOXY]QUINOLIN 4 YLOXY]PHENYL] 4 (2,4 DIMETHOXYPHENYL)PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (4 METHYLPIPERAZIN 1 YL) PROPOXY]QUINOLIN 4 YLOXY]PHENYL] 4 (4 FLUOROPHENYL)PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (4 METHYLPIPERAZIN 1 YL) PROPOXY]QUINOLIN 4 YLOXY]PHENYL] 4 (4 METHOXYPHENYL)PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (4 METHYLPIPERAZIN 1 YL) PROPOXY]QUINOLIN 4 YLOXY]PHENYL] 4 [4 (TRIFLUOROMETHYL)PHENYL]PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (4 METHYLPIPERAZIN 1 YL) PROPOXY]QUINOLIN 4 YLOXY]PHENYL] 4 O TOLYPICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (4 METHYLPIPERAZIN 1 YL) PROPOXY]QUINOLIN 4 YLOXY]PHENYL] 4 P TOLYPICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (4 METHYLPIPERAZIN 1 YL) PROPOXY]QUINOLIN 4 YLOXY]PHENYL] 4 PHENYLPICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (PIPERIDIN 1 YL)PROPOXY] QUINOLIN 4 YLOXYL]PHENYL] 4 (4 FLUOROPHENYL)PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (PIPERIDIN 1 YL)PROPOXY] QUINOLIN 4 YLOXYL]PHENYL] 4 P TOLYLPICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (PIPERIDIN 1 YL)PROPOXY] QUINOLIN 4 YLOXYL]PHENYL] 4 PHENYLPICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (PYRROLIDIN 1 YL)PROPOXY] QUINOLIN 4 YLOXYL]PHENYL] 4 (2,4 DIMETHOXYPHENYL)PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (PYRROLIDIN 1 YL)PROPOXY] QUINOLIN 4 YLOXYL]PHENYL] 4 (4 FLUOROPHENYL)PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (PYRROLIDIN 1 YL)PROPOXY] QUINOLIN 4 YLOXYL]PHENYL] 4 (4 METHOXYPHENYL)PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (PYRROLIDIN 1 YL)PROPOXY] QUINOLIN 4 YLOXYL]PHENYL] 4 (4,2 FLUOROPHENYL)PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (PYRROLIDIN 1 YL)PROPOXY] QUINOLIN 4 YLOXYL]PHENYL] 4 [4 (TRIFLUOROMETHYL)PHENYL]PICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (PYRROLIDIN 1 YL)PROPOXY] QUINOLIN 4 YLOXYL]PHENYL] 4 O TOLYLPICOLINAMIDE;
N [3 FLUORO 4 [6 METHOXY 7 [3 (PYRROLIDIN 1 YL)PROPOXY] QUINOLIN 4 YLOXYL]PHENYL] 4 P TOLYLPICOLINAMIDE;
QUINOLINE DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANTINEOPLASTIC ACTIVITY;
ANTIPROLIFERATIVE ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG DESIGN;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IC 50;
IN VITRO STUDY;
STRUCTURE ACTIVITY RELATION;
ANTIPROLIFERATIVE ACTIVITY;
C-MET;
QUINOLINE DERIVATIVES;
SYNTHESIS;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CELL PROLIFERATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DESIGN;
DRUG SCREENING ASSAYS, ANTITUMOR;
ENZYME ACTIVATION;
HT29 CELLS;
HUMANS;
MOLECULAR STRUCTURE;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS C-MET;
QUINOLINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84883262213
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2013.08.019 Document Type: Article |
Times cited : (54)
|
References (29)
|